Then, youre paying to take the drug for the rest of your life just so you dont lose ground and re gain everything, while continuing to face any and all long-term side effects
From there, KDIGO supports what is often described as a four-pillar framework in T2D CKD: RAAS inhibition as the base, followed by SGLT2 inhibitors, non-steroidal MRAs for T2D with albuminuric CKD, and GLP-1 receptor agonists for T2D with CKD layered to reduce kidney and cardiovascular risk
The positive stories you hear are personal reports, not scientific proof
To put that in perspective, this level of weight reduction is comparable to what can be seen after some forms of bariatric surgery, but achieved through a peptide-based therapy
Measurement of serum methylmalonic acid should be used to confirm deficiency in asymptomatic high-risk patients with low-normal levels of vitamin B 12